Thanks to a $4.3 million award, CvilleBioHub is building out a laboratory accelerator providing resources to up-and-coming ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price dropped 3.8% during trading on Friday . The stock traded as low as $10.81 and last traded at $10.78. Approximately 201,759 shares ...

Jonathan Rigby, President and CEO of Sernova, stated, “We are thrilled to welcome Ross Haghighat as our new Chair of the Board. His deep industry knowledge and visionary leadership make him the ...

Accomplished Business and Financial Leader, Laura Brege, Appointed Chair ---- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ...

The need to harness and tap into numerous benefits of Genetically Modified Organisms (GMOS) has become paramount in the prevailing food insecurity being witness in the country. However, the battle for ...

Dr. Beaurang has over 25 years of experience in biotechnology focusing on corporate strategy, business development, oncology, immunology and neurology. Dr. Beaurang was most recently CEO and member of ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

Unlike some of the other Ark ETFs, the Innovation ETF has a broad focus, aiming to find the most innovative companies in the world. The top five holdings of the Ark Innovation ETF are Tesla, Coinbase, ...